CLINICAL_TRIALS
trial_result
· 2008-04-08
Clinical Trial Update: Topical Ocular Mecamylamine in Diabetic Macular Edema (DME) [Phase 2]
Summary
This document notes the completion of a Phase 2 trial evaluating topical mecamylamine for diabetic macular edema.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CoMentis | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED